Biosurgical Agents | Market Insights | US | 2025
The biosurgical agent market in the US will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical hemostats, the launch of new products with improved clinical efficiency, and high awareness among physicians about the clinical benefits of biosurgical agents in various procedures and their extended applications.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biosurgical agents in the US from 2019 through 2033.